All Comments by Paul Coleman

  1. Quantification of cholinergic and select non-cholinergic mesopontine neuronal populations in the human brain.
  2. A test of odor fluency in patients with Alzheimer's and Huntington's disease.
  3. Hyperphosphorylated tau in SY5Y cells: similarities and dissimilarities to abnormally hyperphosphorylated tau from Alzheimer disease brain.
  4. Multivariate analysis of laminar patterns of neurodegeneration in posterior cingulate cortex in Alzheimer's disease.
  5. Cholinergic markers in elderly patients with early signs of Alzheimer disease.
  6. Two-dimensional map of human brain proteins.
  7. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging.
  8. Alzheimer neuropathologic alterations in aged cognitively normal subjects.
  9. Elevation of cerebral proteases after systemic administration of aluminum.
  10. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.
  11. The regulation of phosphorylation of tau in SY5Y neuroblastoma cells: the role of protein phosphatases.
  12. Diabetes and dementia in long-term care.
  13. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain.
  14. Link Between Education Level and AD Risk Strengthened